Skip to main content
Clinical Trials/EUCTR2015-003177-14-ES
EUCTR2015-003177-14-ES
Active, not recruiting
Phase 1

Paracetamol versus ibuprofen in preterm infants with a hemodynamically significant patent ductus arteriosus: a randomized clinical trial.

Not provided0 sitesApril 20, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Persistent ductus arteriosus haemodynamically significant
Sponsor
Not provided
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2016
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Not provided

Eligibility Criteria

Inclusion Criteria

  • ? Informed consent signed by parents or legal representative.
  • ? Gestational age ? 30 weeks.
  • ? Postnatal age ? 2 weeks
  • ? 1st episode of hemodynamically significant PDA diagnosed by ultrasound:
  • 1\. Continuous flow through DAP.
  • 2\. Retrograde diastolic flow in the descending aorta.
  • 3\. Strain the left atrium. (relationship left atrium / aorta (LA / AO)\> 1\.5\).
  • 4\. Ductal diameter greater than 1\.7 mm.
  • 5\. Relationship ductus / descending aorta diameter size greater than 0\.5\.
  • ? Need for ventilatory support

Exclusion Criteria

  • \- Gestational age\> 30 weeks
  • \- Postnatal age\> 2 weeks
  • \- Major congenital malformations.
  • \- Impending doom.
  • \- Chromosomopaties.
  • \- Refusal to participate and / or sign the informed consent.
  • \- Inability to randomization or scrambling wrong.
  • \- Participation in another clinical trial
  • \- Diuresis less than 1 ml / kg / h for 8 h prior to treatment
  • \- Greater than 1\.8 mg / dl Creatinine

Outcomes

Primary Outcomes

Not specified

Similar Trials